Insulet Corp (PODD) Price to Earnings Ratio

Corporate emblem and logo of Insulet Corp (PODD)

Insulet Corporation (PODD) is implementing advanced robotics and closed-loop algorithms for diabetes management. The price-to-earnings ratio reflects the asset's dynamics, where 23.90 determines this specific parameter level. Despite pressure from medtech behemoths, Insulet Corporation (PODD) maintains its leadership through patents for Omnipod tubeless pumps and convenient sales via pharmacy chains.

Insulet Inc. (PODD) Price to Earnings Ratio: for the period 07/04/2022 - 11/12/2026

Comprehensive metric breakdowns and analytics for OmniPod (PODD)

- price and consensus price forecast:
Stock Price insulet.com|PODD - Price Target Chart
- market capitalization details:
Market Value Insulet Corporation|PODD - Enterprise Value
- book capitalization information:
Net Assets per Share Insulet|PODD - Company Net Assets|Market Capitalization to Net Assets insulet.com|PODD - Company Total Assets
- debt and solvency information:
Debt to Capital Insulet Corporation|PODD - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Insulet Inc.|PODD - Company Total Debt|Debt to Net Assets Ratio Insulet Corporation|PODD - Company Long-Term Debt|Company Current Liabilities Insulet|Immediate Liquidity insulet.com
- earnings and market multiples details:
PODD - Net Profit|Net Profit Forecast Insulet Corporation|PODD - P/E Multiple|Market Cap to Projected Earnings Insulet Corp|PODD - PEG Multiple|Enterprise Value to EBITDA Ratio Insulet Corporation|PODD - Operating profit EBITDA|Net earnings per share (EPS TTM) Insulet|PODD - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months insulet.com|PODD - Net earnings per share growth this year|Expected earnings per share trend next year Insulet Corporation
General company analysis:insulet.com - PODD
Original product of insulet.com

The P/E valuation for Insulet Corporation (PODD) reflects market expectations regarding the efficiency of its diversified logistics and manufacturing capacities. This ratio compares the current market share price to net income, determining the investment payback period. The metric's high sensitivity to earnings growth forecasts makes it an indicator of whether the asset is overbought or undervalued. Stable insulin pump supplies via backup lines in the US and Europe fundamentally support the resilience of this multiple.

Analysis of competing companies

P/E Multiple bostonscientific.com|Price to Earnings Ratio Edwards Lifesciences Corporation (EW)|Price to Earnings Ratio RMD (ResMed Inc)|P/E Multiple ZBH (zimmerbiomet.com)|Business Payback Period CooperSurgical (COO)|ALGN: Price to Earnings Ratio|Market Cap to Net Income GMED|TMDX: P/E Multiple|Market Cap to Earnings Alphatec Holdings (ATEC)|AORT (Artivion Inc) - P/E Multiple|Price to Earnings Multiple ENOV (Enovis Inc.)|Price to Earnings Ratio IART (Integra LifeSciences)|ESTA (establishmentlabs.com) - Company Value to Net Income|Price to Earnings Ratio Beta Bionics BBNX|IRMD - Price to Earnings Ratio|Embecta Inc. - P/E Multiple|Market Cap to Earnings Tandem Corp|AXGN: P/E Multiple|Price to Earnings Multiple SIBN|OFIX (Orthofix) - P/E Multiple|Bioventus Inc (BVS) - Business Payback Period|P/E Multiple KIDS|Price to Earnings Ratio Treace Corp TMCI|P/E Multiple SRTA (Strata Critical Medical Inc)|P/E Multiple carlsmed.com CARL|RXST - Price to Earnings Ratio|CLPT: Price to Earnings Ratio|STXS (Stereotaxis Corp) - Price to Earnings Ratio|Neuronetics, Inc - Company Value to Net Income|SGHT (Sight Sciences, Inc.) - P/E Multiple|Market Cap to Earnings orchestrabiomed.com OBIO|Price to Earnings Ratio Anika Therapeutics (ANIK)|InspireMD Inc (NSPR) - Market Cap to Net Income Ratio|Jin Medical - Price to Earnings Ratio|P/E Multiple Vivani Medical Inc VANI|Xtant Medical Inc - P/E Multiple|Business Payback Period n1mtc.com NMTC|modular-medical.com (MODD) - Price to Earnings Ratio|Market Cap to Net Income MYO (Myomo Inc.)|Price to Earnings Ratio Envoy Medical, Inc|Price to Earnings Ratio Vivos Therapeutics Inc (VVOS)|P/E Multiple NVNO|SINT - Market Cap to Earnings|Price to Earnings Ratio Tenon Medical TNON|LFWD: Price to Earnings Multiple|AMIX: Price to Earnings Ratio|INVO Fertility Corp - Market Price to Net Income Ratio|BBLG: P/E Multiple|AXNX - Business Payback Period|Price to Earnings Ratio BIOLASE|Price to Earnings Multiple DYNT (Dynatronics Corp.)|Price to Earnings Ratio Paragon 28, Inc. (FNA)|Business Payback Period invobioscience.com